Gertsenstein M, Lintott L, Nutter L
Curr Protoc. 2025; 5(2):e70109.
PMID: 39999224
PMC: 11856344.
DOI: 10.1002/cpz1.70109.
Jin Y, Zhang P, Liu L, Zhao X, Hu X, Liu S
Nat Commun. 2024; 15(1):6843.
PMID: 39122671
PMC: 11315919.
DOI: 10.1038/s41467-024-50788-x.
Maino E, Scott O, Rizvi S, Chan W, Visuvanathan S, Zablah Y
Dis Model Mech. 2024; 17(7).
PMID: 38881329
PMC: 11552499.
DOI: 10.1242/dmm.050528.
Shi H, Li L, Mu S, Gou S, Liu X, Chen F
BMC Biol. 2024; 22(1):119.
PMID: 38769511
PMC: 11107001.
DOI: 10.1186/s12915-024-01918-w.
Guo X, Liu C, Zhao Y, Jiang C, Jin J, Liu Z
Animals (Basel). 2024; 14(4).
PMID: 38396618
PMC: 10886166.
DOI: 10.3390/ani14040650.
Genetically modified mice as a tool for the study of human diseases.
Bruter A, Varlamova E, Okulova Y, Tatarskiy V, Silaeva Y, Filatov M
Mol Biol Rep. 2024; 51(1):135.
PMID: 38236499
DOI: 10.1007/s11033-023-09066-0.
Engineering Tripartite Gene Editing Machinery for Highly Efficient Non-Viral Targeted Genome Integration.
Nam H, Xie K, Majumdar I, Yang S, Starzyk J, Lee D
Res Sq. 2023; .
PMID: 37961210
PMC: 10635301.
DOI: 10.21203/rs.3.rs-3365585/v1.
Diverse Systems for Efficient Sequence Insertion and Replacement in Precise Plant Genome Editing.
Zhang Y, Qi Y
Biodes Res. 2023; 2020:8659064.
PMID: 37849897
PMC: 10530650.
DOI: 10.34133/2020/8659064.
CRISPR-Cas9 Direct Fusions for Improved Genome Editing via Enhanced Homologous Recombination.
Tabassum T, Pietrogrande G, Healy M, Wolvetang E
Int J Mol Sci. 2023; 24(19).
PMID: 37834150
PMC: 10572186.
DOI: 10.3390/ijms241914701.
A potential paradigm in CRISPR/Cas systems delivery: at the crossroad of microalgal gene editing and algal-mediated nanoparticles.
Feng S, Xie X, Liu J, Li A, Wang Q, Guo D
J Nanobiotechnology. 2023; 21(1):370.
PMID: 37817254
PMC: 10563294.
DOI: 10.1186/s12951-023-02139-z.
Loading characteristics of streptavidin on polypropylene capillary channeled polymer fibers and capture performance towards biotinylated proteins.
Bin Islam M, Marcus R
Anal Bioanal Chem. 2023; 415(27):6711-6721.
PMID: 37740120
DOI: 10.1007/s00216-023-04948-5.
A Cell-Based Optimised Approach for Rapid and Efficient Gene Editing of Human Pluripotent Stem Cells.
Cuevas-Ocana S, Yang J, Aushev M, Schlossmacher G, Bear C, Hannan N
Int J Mol Sci. 2023; 24(12).
PMID: 37373413
PMC: 10299534.
DOI: 10.3390/ijms241210266.
CATI: an efficient gene integration method for rodent and primate embryos by MMEJ suppression.
Chen H, Liu X, Li L, Tan Q, Li S, Li L
Genome Biol. 2023; 24(1):146.
PMID: 37353834
PMC: 10288798.
DOI: 10.1186/s13059-023-02987-w.
Efficient precise integration of large DNA sequences with 3'-overhang dsDNA donors using CRISPR/Cas9.
Han W, Li Z, Guo Y, He K, Li W, Xu C
Proc Natl Acad Sci U S A. 2023; 120(22):e2221127120.
PMID: 37216515
PMC: 10235934.
DOI: 10.1073/pnas.2221127120.
Strategies for precise gene edits in mammalian cells.
Fichter K, Setayesh T, Malik P
Mol Ther Nucleic Acids. 2023; 32:536-552.
PMID: 37215153
PMC: 10192336.
DOI: 10.1016/j.omtn.2023.04.012.
MDM2 antagonists promote CRISPR/Cas9-mediated precise genome editing in sheep primary cells.
Li Y, Lian D, Wang J, Zhao Y, Li Y, Liu G
Mol Ther Nucleic Acids. 2023; 31:309-323.
PMID: 36726409
PMC: 9883270.
DOI: 10.1016/j.omtn.2022.12.020.
Precise gene replacement in plants through CRISPR/Cas genome editing technology: current status and future perspectives.
Li S, Xia L
aBIOTECH. 2022; 1(1):58-73.
PMID: 36305005
PMC: 9590512.
DOI: 10.1007/s42994-019-00009-7.
Development of an in vivo cleavable donor plasmid for targeted transgene integration by CRISPR-Cas9 and CRISPR-Cas12a.
Ishibashi R, Maki R, Kitano S, Miyachi H, Toyoshima F
Sci Rep. 2022; 12(1):17775.
PMID: 36272994
PMC: 9588054.
DOI: 10.1038/s41598-022-22639-6.
Screening DNA aptamers that control the DNA cleavage, homology-directed repair, and transcriptional regulation of the CRISPR-(d)Cas9 system.
Huang X, Wang M, Wu X, Zou Y, Xu J, Cao C
Mol Ther. 2022; 31(1):260-268.
PMID: 36245127
PMC: 9840146.
DOI: 10.1016/j.ymthe.2022.10.009.
Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems.
Shams F, Bayat H, Mohammadian O, Mahboudi S, Vahidnezhad H, Soosanabadi M
Bioimpacts. 2022; 12(4):371-391.
PMID: 35975201
PMC: 9376165.
DOI: 10.34172/bi.2022.23871.